In particular, loss-of-function mutations in the WNT  co-receptor LRP5 (low-density lipoprotein receptor-related protein 5) result in low bone mass in osteoporosis-pseudoglioma syndrome, whereas gain-of-function mutations in LRP5 markedly increase bone mass in otherwise healthy individuals.10 This evidence concerns the gene LRP5 and osteoporosis.